Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$17.5B |
| 2 |
NVIDIA
NVDA
|
+$2.7B |
| 3 |
Intel
INTC
|
+$1.98B |
| 4 |
Broadcom
AVGO
|
+$1.46B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$35.8B |
| 2 |
Apple
AAPL
|
+$1.83B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$913M |
| 4 |
Microsoft
MSFT
|
+$856M |
| 5 |
Bank of America
BAC
|
+$792M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.47% |
| 2 | Technology | 19.84% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 5.61% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5251
Beam Global
BEEM
$16.3M
| $1 | ﹤0.01% |
+1
| New | +$1 |
2026 Q3
0 quarters
|
|
5252
Bullfrog AI
BFRG
$9.6M
| $1 | ﹤0.01% |
1
-1,032
| -100% | -$610 |
2026 Q2
1 quarter
|
|
5253
Clean Energy Technologies
CETY
$10.8M
| $1 | ﹤0.01% |
1
-271
| -100% | -$260 |
2026 Q2
1 quarter
|
|
5254
Educational Development Corp
EDUC
$7.59M
| $1 | ﹤0.01% |
+1
| New | +$1 |
2026 Q3
0 quarters
|
|
5255
Estrella Immunopharma
ESLA
$16.3M
| $1 | ﹤0.01% |
2
-124
| -98% | -$88 |
2026 Q2
1 quarter
|
|
5256
New Concept Energy
GBR
$4.29M
| $1 | ﹤0.01% |
+1
| New | +$1 |
2026 Q3
0 quarters
|
|
5257
Hydrofarm Holdings
HYFM
$3.93M
| $1 | ﹤0.01% |
+1
| New | +$1 |
2026 Q3
0 quarters
|
|
5258
IGC Pharma
IGC
$20.7M
| $1 | ﹤0.01% |
4
-717
| -99% | -$199 |
2026 Q2
1 quarter
|
|
5259
DELISTED
Iterum Therapeutics
ITRM
| $1 | ﹤0.01% |
10,795
| – | – |
2026 Q2
1 quarter
|
|
5260
GEE Group
JOB
$20.8M
| $1 | ﹤0.01% |
5
-406
| -99% | -$92 |
2026 Q2
1 quarter
|
|
5261
Loop Industries
LOOP
$12.3M
| $1 | ﹤0.01% |
3
-113
| -97% | -$73 |
2026 Q2
1 quarter
|
|
5262
Natural Alternatives International
NAII
$6.95M
| $1 | ﹤0.01% |
+1
| New | +$2 |
2026 Q3
0 quarters
|
|
5263
Organigram Holdings
OGI
$126M
| $1 | ﹤0.01% |
1
| – | – |
2022 Q1
18 quarters
|
|
5264
Onconetix
ONCO
$4.09M
| – | – |
0
| – | – |
2026 Q3
0 quarters
|
|
5265
Oxbridge Re Holdings
OXBR
$7.11M
| $1 | ﹤0.01% |
+1
| New | +$1 |
2026 Q3
0 quarters
|
|
5266
Pliant Therapeutics
PLRX
$50.1M
| $1 | ﹤0.01% |
1
-425
| -100% | -$471 |
2022 Q1
18 quarters
|
|
5267
Research Frontiers
REFR
$12.8M
| $1 | ﹤0.01% |
2
-152
| -99% | -$76 |
2026 Q2
1 quarter
|
|
5268
Southland Holdings
SLND
$37.2M
| $1 | ﹤0.01% |
2
-806
| -100% | -$526 |
2023 Q2
13 quarters
|
|
5269
SenesTech
SNES
$5.97M
| $1 | ﹤0.01% |
1
-105
| -99% | -$123 |
2026 Q2
1 quarter
|
|
5270
Theriva Biologics
TOVX
$7.64M
| $1 | ﹤0.01% |
3
| – | – |
2026 Q2
1 quarter
|
|
|
VJET
5271
Flyte Aviation, Inc.
VJET
$1.1M
| $1 | ﹤0.01% |
+1
| New | +$3 |
2026 Q3
0 quarters
|
|
|
XXII
5272
22nd Century Group
XXII
$854K
| – | – |
-3
| Closed | -$580 | – |
|
5273
AtlasClear
ATCH
$20.6M
| $1 | ﹤0.01% |
4
-2,411
| -100% | -$451 |
2026 Q2
1 quarter
|
|
5274
Armlogi Holding Corp
BTOC
$5.2M
| – | – |
0
| – | – |
2026 Q3
0 quarters
|
|
5275
Q/C Technologies Inc
QCLS
$2.79M
| $1 | ﹤0.01% |
1
-949
| -100% | -$2.31K |
2026 Q2
1 quarter
|
|
Similar funds
Barclays's Q3 2026 Portfolio in Review
As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.
- Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
- Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
- Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
- Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
- Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
- Barclays opened 525 new positions and closed 474 in Q3 2026.
- Barclays's portfolio value fell 4% quarter-over-quarter to $500B.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.